Epitopea (private company)
See something wrong or missing? Let us know
Offices:Cambridge
Industry:BiotechHealth servicesPharma
Business model:B2B
Epitopea is a startup from Cambridge UK developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication
Investors:
we tracked 10 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 44.41M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Epitopea
Name | Criteria | |
---|---|---|
![]() |
Causaly
80%
|
|
![]() |
Kither Biotech
80%
|
|
![]() |
Relation Therapeutics
80%
|
|
![]() |
CorFlow Therapeutics
80%
|
|
![]() |
Cinclus Pharma
77%
|
|
![]() |
SolasCure
77%
|
|
![]() |
ViaNautis
77%
|
|
![]() |
Octarine Bio
75%
|
|
![]() |
CardiaTec Biosciences
75%
|
|
![]() |
Mable
75%
|
|